Thursday, July 29

AstraZeneca

AstraZeneca, combinar, Corea del Sur, coronavirus, Covid 19, dosis, Noticias, Pfizer, Salud, vacuna, vacunacion

Study Shows Advantages of Combining Pfizer and AstraZeneca | Digital Trends Spanish

A study carried out in South Korea showed that a mixed COVID-19 vaccination of AstraZeneca and then an injection of Pfizer increased the levels of neutralizing antibodies by six times, compared to two doses of AstraZeneca. About 500 medical workers participated in the research. Of these, 100 received mixed doses, 200 received two doses of the Pfizer / BioNTech vaccine, and the remainder received two AstraZeneca vaccines. According to a Reuters articleAll showed neutralizing antibodies, which prevent the virus from entering cells and replicating, and the result of the mixed vaccine plan showed similar amounts of neutralizing antibodies found in the group that received two injections from Pfizer. A neutralizing activity was also detected against the main variants of greatest interest, ac...
AstraZeneca, coronavirus, COVID-19 vaccine, delta variant, pfizer vaccine, Public Health, Science

Pfizer’s COVID-19 vaccine works very well against the Delta variant — but only after 2 doses

A UK study suggests two-dose Pfizer and AstraZeneca vaccines work well against Delta infections. After one shot, the vaccines were only 30% to 36% effective against symptomatic Delta infections. But with two shots, Pfizer's and AstraZeneca's vaccines were 88% and 67% effective, respectively. LoadingSomething is loading. A study of more than 19,...
AstraZeneca, coronavirus, Healthcare, Science, Seychelles, Sinopharm

6 fully vaccinated people died of COVID-19 in the world’s most vaccinated nation, health officials said. All had underlying health conditions.

Six fully-vaccinated people have died in Seychelles, Jude Gedeon, public health commissioner, said. Five had received Covishield, an India-made version of AstraZeneca's shot, and one had Sinopharm. All of those who died had underlying health conditions, Gedeon said. See more stories on Insider's business page. Six people have died from COVID-19 in the Seychelles despite being fully vaccinated, according to the country's public health commissioner.Jude Gedeon said on Thursday that five of the people had received Covishield, a version of AstraZeneca's COVID-19 vaccine manufactured in India, and that one had received China's Sinopharm...
AstraZeneca, booster shot, coronavirus, COVID-19 vaccine, Johnson & Johnson, Moderna, Pfizer, Science

Early findings indicate that mixing and matching coronavirus vaccines might improve your protection

The evidence in favor of a mix-and-match approach to coronavirus shots is growing.Early data from a UK study, though not yet been peer reviewed, indicates that mixing the Pfizer and AstraZeneca vaccines yields a greater immune response than two doses of AstraZeneca's shot. The researchers measured antibody levels among 830 volunteers who received either two doses of the same vaccine or a combination of Pfizer and AstraZeneca, four weeks apart.Volunteers who got AstraZeneca's shot followed by Pfizer's showed nearly the same antibody levels — and an even higher number of T-cells — as those who'd received two doses of Pfizer. By contrast, volunteers who got Pfizer's shot first and AstraZeneca's second had slightly lower antibody...
AstraZeneca, Covid 19, Noticias, Pfizer, Salud, vacunas

Mixing vaccines increases protection against COVID-19 | Digital Trends Spanish

The scientific community received preliminary good news this Monday, June 28, since A study of the University of Oxford indicated that the combination of vaccines is more effective in protecting against COVID-19. The expert and project leader, Matthew Snape, specifically addressed the AstraZeneca and Pfizer mix and in any order of administration. In the first run of the study, 830 volunteers were given one of four vaccine combinations. Some received two doses of Pfizer or AstraZeneca, which have been shown to be effective against Covid-19. Others received a dose of AstraZeneca, followed by a dose of Pfizer, or vice versa. One of the downsides was adverse effects, as the researchers found that volunteers reported more chills, headaches and muscle pain than people receiving two doses of...
AstraZeneca, Covid 19, Noticias, Pfizer, Salud, Variante Delta, Variante Kappa

Measure the effectiveness of Pfizer and Astrazeneca against Delta | Digital Trends Spanish

An important study from the University of Oxford revealed the level of effectiveness of the Pfizer and AstraZeneca vaccines against the contagious Delta variant of COVID-19. The study, published in the journal Cell, looked at the ability of antibodies in the blood of people, who were vaccinated with the two-injection regimens, to neutralize the highly contagious Delta and Kappa variants, according to a statement. In fact, a few days ago he had settled in Britain for the Public Health England, that the two doses of either of the two vaccines, would help 90% in avoiding hospitalization for Delta. Shuttersteck."We are encouraged to see the non-clinical results published from Oxford and these data, together with the recent early real-world analysis from Public Health England, give us a posi...
AstraZeneca, coronavirus, Covid 19, cura efectiva, distribucion, dosis, ensayos clinicos, fase avanzada, Noticias, pacientes, pandemia, Salud, Universidad de Oxford, vacuna, vacuna de oxford, verificación

AstraZeneca reports on distribution of its vaccine | Digital Trends Spanish

Josep Baselga is the director of AstraZeneca's Oncology Research and Development area. In conversation with Spanish media, the professional has ensured that the vaccine developed by the pharmaceutical company against COVID-19 could be in an advanced distribution phase at the end of the first quarter of next year. Baselga has pointed out that by early 2021, the company would have some three billion doses of vaccines that it hopes can be verified as effective. The difficult thing, in this case, would be to find a practical and effective way to distribute them due to the high demand that will exist. For its part, AstraZeneca hopes that before the end of this year, some of the four vaccines it is experimenting with will start to show results. Shutterstock. It is estimated that this vac...
AstraZeneca, coronavirus, Covid 19, Noticias, Salud

Oxford Exonerates COVID-19 Vaccine Of Adverse Reaction | Digital Trends Spanish

The "severe adverse reaction" in one of the participants that led to the temporary suspension of human trials of the AstraZeneca COVID-19 vaccine were not related to the application of the antidote. This is stated in a document published on September 16 by the University of Oxford, which develops the vaccine in conjunction with the British pharmaceutical company. AstraZeneca and the University of Oxford had started phase 3 of the study at the end of August 2020 to develop an antidote to prevent SARS-CoV-2 infection. However, on September 8 the human trials of its vaccine against COVID-19, because one of the British participants would have had a "serious adverse reaction". Safety reviews began when volunteers developed unexplained neurological symptoms, including limb we...
AstraZeneca, coronavirus, Covid 19, enfermedades zoonóticas, Noticias, Salud, Universidad de Oxford

Scientist predicts new viruses transmitted by animals | Digital Trends Spanish

The hope of much of the planet for a vaccine against the coronavirus rests on the shoulders of scientists such as Professor Sarah Gilbert of the University of Oxford, who is leading one of the most promising trials. The British institution works in conjunction with its pharmaceutical partner AstraZeneca. It is currently awaiting the results of phase 3 trials. If they demonstrate a high level of efficacy, the vaccine could be available by the end of 2020. But COVID-19 and its vaccine could be just part of the beginning of a cycle of dangerous new diseases, Sarah Gilbert said in an interview conducted by The Independent. As an authorized voice in health, the scientist warns that new outbreaks of diseases transmitted from animals to humans will appear in the coming years....
AstraZeneca, coronavirus, Covid 19, México y Argentina, Noticias, Producción de vacuna, Salud, Universidad de Oxford

Mexico and Argentina will produce vaccine against COVID-19 for Latin America | Digital Trends Spanish

After Russia became the first country to grant regulatory approval to a vaccine against COVID-19, and with the "impatient" wait for the WHO to analyze the results of its clinical tests, this Wednesday, August 12, it emerged that Mexico and Argentina will contribute to the production of the AstraZeneca vaccine for Latin America. “The laboratory (AstraZeneca) has signed an agreement with the Carlos Slim Foundation (Mexico) to produce between 150 and 250 million vaccines destined for all of Latin America —with the exception of Brazil—, which will be available by the first half of 2021 and that will be distributed equitably among the countries that demand it ”, explained Alberto Fernández, president of Argentina. Pexels The president recalled that the possible vaccine, deve...